Nabriva Therapeutics Enters into Exclusive Agreement to Promote and Distribute SIVEXTRO® (tedizolid phosphate) in the U.S.

Ads

You May Also Like

Cancer Genetics, Inc. Announces Pricing of Public Offering of Common Stock

RUTHERFORD, N.J., Jan. 09, 2019 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a ...

SIGA to Present at the Jefferies Global Healthcare Conference on June 8, 2018

NEW YORK, May 31, 2018 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ:SIGA), a commercial-stage ...

NeoGenomics Announces Participation in NCI-MATCH Clinical Trial

FT. MYERS, Fla., Sept. 24, 2018 (GLOBE NEWSWIRE) -- NeoGenomics Laboratories, Inc. (NASDAQ: NEO), ...